For a complete list of publications see:

Al-Rawi S, Meehan-Andrews T,  Bradley C and Al-Rawi J (2014) Novel benzoxazines as inhibitors of angiogenesis, Invest New Drugs, 33(1): 45-52.

Radhamani S, Bradley C, Meehan-Andrews T, Ihmaid SK, Al-Rawi JMA and Angove MJ (2014) Radiosensitizing activity of selected substituted Benzoxazines through the promotion of apoptosis and inhibition of DNA repair, Invest New Drugs, 32(3): 424-35.

Fitzgibbon C, Ihmaid S, Al-Rawi J, Meehan-Andrews T and Bradley C (2013) Chemo-sensitisation of HeLa cells to Etoposide by a Benzoxazine in the absence of DNA-PK inhibition, Invest New Drugs, 31(6): 1466-75.

Ihmaid SK, Al-Rawi JMA, Bradley CJ, Angove MJ and Robertson MN (2012) Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7, 8-di and 8-substituted)-1,3-benzoxazines, Eur J Med Chem., 57: 85-101.

Ihmaid S, Al-Rawi J, Bradley C, Angove MJ, Robertson MN and Clark RL (2011) Synthesis, structural elucidation, DNA-PK inhibition, homology modeling and anti-platelet activity of morpholino-substituted-1,3-naphth-oxazines, Bioorg Med Chem., 19(13): 3983-94.

Ihmaid S, Al-Rawi J and Bradley C (2010) Synthesis, structural elucidation and `DNA-dependant protein kinase and antiplatelet studies of 2-amino-[5, 6, 7, 8- mono and 7, 8-di-substituted]-1,3-benzoxazines, Eur J Med Chem., 45(11): 4934-46.